BIVI - Biovie - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $213.93. This is a potential upside of $212.63 (16356.15%) from yesterday's end of day stock price of $1.3.

Biovie's activity chart (see below) currently has 14 price targets and 14 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 58.33% with an average time for these price targets to be met of 221 days.

Most recent stock forecast was given by JAY OLSON from OPPENHEIMER on 30-Nov-2023. First documented stock forecast 15-Jan-2021.

Best performing analysts who are covering BIVI - Biovie:

Mayank Mamtani Constantine Davides Jay Olson Charles Duncan

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 15-Mar-2022

$1200

2 years 1 months 9 days ago
(30-Nov-2023)

1/3 (33.33%)

$482 (67.13%)

268

Buy

Since 22-Jul-2022

$1100

$1098.67 (82606.77%)

$1100

2 years 4 months 17 days ago
(22-Aug-2023)

1/4 (25%)

$744 (208.99%)

132

Buy

Since 17-Mar-2022

$80

$78.67 (5915.04%)

$140

3 years 3 months 11 days ago
(28-Sep-2022)

2/2 (100%)

$-176 (-68.75%)

316

Buy

Since 15-Jan-2021

$180

$178.67 (13433.83%)

$270

3 years 11 months 15 days ago
(24-Jan-2022)

3/4 (75%)

$-199.5 (-52.57%)

168

Show more analysts

Please expand the browser size to see the chart

What is BIVI (Biovie) average time for price targets to be met?

On average it took 221 days on average for the stock forecasts to be realized with a an average price target met ratio 58.33

Which analyst has the current highest performing score on BIVI (Biovie) with a proven track record?

MAYANK MAMTANI

Which analyst has the current lower performing score on BIVI (Biovie) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on BIVI (Biovie)?

Mayank Mamtani works at B. RILEY and has 2 price targets and 1 ratings on BIVI

Which analyst is the currently most bullish on BIVI (Biovie)?

Charles Duncan with highest potential upside - $1098.67

Which analyst is the currently most reserved on BIVI (Biovie)?

Jay Olson with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?